Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immucell (ICCC) Long-Term Deferred Tax (2016 - 2022)

Immucell's Long-Term Deferred Tax history spans 12 years, with the latest figure at $665313.0 for Q4 2022.

  • For Q4 2022, Long-Term Deferred Tax rose 752.02% year-over-year to $665313.0; the TTM value through Dec 2022 reached $665313.0, up 752.02%, while the annual FY2022 figure was $665313.0, 752.02% up from the prior year.
  • Long-Term Deferred Tax reached $665313.0 in Q4 2022 per ICCC's latest filing, up from $78087.0 in the prior quarter.
  • In the past five years, Long-Term Deferred Tax ranged from a high of $665313.0 in Q4 2022 to a low of $78087.0 in Q4 2021.
  • Average Long-Term Deferred Tax over 4 years is $450704.0, with a median of $504236.0 recorded in 2018.
  • Peak YoY movement for Long-Term Deferred Tax: skyrocketed 2575.65% in 2018, then tumbled 82.36% in 2021.
  • A 4-year view of Long-Term Deferred Tax shows it stood at $563252.0 in 2018, then dropped by 21.41% to $442632.0 in 2020, then crashed by 82.36% to $78087.0 in 2021, then soared by 752.02% to $665313.0 in 2022.
  • Per Business Quant, the three most recent readings for ICCC's Long-Term Deferred Tax are $665313.0 (Q4 2022), $78087.0 (Q4 2021), and $442632.0 (Q4 2020).